Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis

NCT00594932 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
Arthritis

Interventions

DRUG: mycophenolate mofetil
OTHER: placebo

Sponsor

Oklahoma Medical Research Foundation

Collaborators

[object Object]